EUnetHTA Conference: HTA's Future in Europe

November 20, 2008
Pasteur Institute, Paris, France
Health technology is the application of scientific knowledge in health care and prevention. Health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology in a systematic, transparent, unbiased, robust manner. Its aim is to inform the formulation of safe, effective, health policies that are patient focused and seek to achieve best value.

Detailed programme will be available at a later date. To receive updated information regarding the conference, please subscribe to the update service at http://www.eunethta.net/Home/
EUnetHTA_Conference_2008_in__Paris/

The plenary will include presentations on the results from the EUnetHTA project:

  • Core HTA Model
  • HTA Adaptation toolkit
  • New technologies monitoring system
  • Emerging technologies information system
  • HTA and health policy
  • HTA capacity building
  • EUnetHTA HTA information system

The Conference will be held at the Scientific International Center of the Pasteur Institute.
These facilities are conveniently located downtown Paris (Metro Pasteur; Gare Montparnasse)
The official language of the conference is English. Simultaneous interpretation will be available in French and Spanish.

For further information, please visit:
http://www.eunethta.net/Home/
EUnetHTA_Conference_HTAs_Future_in_Europe/

About European network for Health Technology Assessment (EUnetHTA)
In 2004 the European Commission and Council of Ministers targeted Health Technology Assessment (HTA) as "a political priority", recognising "...an urgent need for establishing a sustainable European network on HTA". A Commission call was answered in 2005 by a group of 35 organisations throughout Europe, led by the Danish Centre for Evaluation and HTA (DACEHTA) in Copenhagen.

European network for Health Technology Assessment, EUnetHTA, coordinates the efforts of 27 European countries including 25 Member States of the European Union in evaluating health technology in Europe.

The general strategic objective of the Network:
to connect public national/regional HTA agencies, research institutions and health ministries, enabling an effective exchange of information and support to policy decisions by the Member States. Specific Objectives...

During the first 3 years of existence (2006-2008) EUnetHTA aims at developing an organisational framework for a sustainable European network for HTA along with practical tools to fill into this framework to ensure timely and effective production, dissemination and transfer of HTA results into useful policy advice to the Member States and EU.

Initially, the EUnetHTA project is being co-financed by the European Commission (DG Sanco) and contributions from network members.

Progress reports and information on EUnetHTA activities involving a wider stakeholder group will be continuously available on the Eunethta website, http://www.eunethta.net.

Most Popular Now

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...